India’s indigenous coronavirus vaccine ‘Covaxin’ shows robust immune response in 1st phase clinical trials
First Published: 17th December, 2020 18:25 IST
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first phase trials of the vaccine
India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials.
A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad-based Bharat Biotech and ICMR has been found to be safe generating no serious adverse effects in people of all dose groups as per the results of the first phase clinical trials.
ICMR has informed that the vaccine can be stored at 2 to 8 degree Celcius temperatures which also makes it compatible with the National Immunization plan.
Covaxin is one among the three coronavirus vaccine candidates being considered for emergency use authorisation in India by the Drug regulator. It is currently in its third and last phase of clinical trials with nearly 26 thousand volunteers in the age group of 18 and 55.
(with inputs from News on Air)
COMMENTS
TOPMOST STORY NOW
Live Tripura: Two polling officials suspended for allowing election-related malpractices in Ramanagar constituency
20th April 2024Live Lok Sabha elections: BSF Meghalaya ensures peaceful polls
20th April 2024Live Manipur LS Polls: 3 arrested in firing incident at Manipur polling station
20th April 2024Live Vishal Kumar, Returning Officer for West Tripura LS seat briefs media
19th April 2024WE RECOMMEND
High turnout in Phase 1 of Lok Sabha Elections 2024 despite heat wave
The Commission led by CEC Rajiv Kumar and ECs Gyanesh Kumar and Sukhbir Singh Sandhu constantly monitored the progress of polling in Phase 1 across the constituencies from ECI Headquarters in Nirvachan Sadan.
19th April 2024Lok Sabha elections 2024 Phase 1: Big faces and high-stakes battles
The candidature of its Tamil Nadu state president shows that the BJP is pressing hard to increase its presence in South India
19th April 2024“You are not innocent”: SC tells Ramdev, he says will remain conscious in future
Co-founder of Patanjali Ayurved Ltd., Ramdev, tendered unconditional apology "for the mistakes", adding that "What we did at the time was not correct. We will be conscious about it in the future."
16th April 2024Need skills to go far beyond Earth’s orbit: ISRO chief Somanath at Inter-Agency Space Debris Coordination Committee
The ISRO chief also issued a declaration saying that India aims to create debris free space missions by 2030.
16th April 2024Five killed, several injured as bus falls from flyover in Odisha’s Jajpur
Chief District Medical Officer (CDMO) Shibasish Moharana said that out of 38 injured, one was seriously injured.
16th April 2024